Taiwan FDA registration f98bfab4b1d0872b6ed05c3a29e6723b
Emex Advanced Triglyceride Monitoring System (Unsterilized)
TW: 易美測 進階型 三酸甘油酯 監測系統 (未滅菌)
Taiwan·Risk Class 1·BIOPTIK TECHNOLOGY, INC.·Registered Sep 26, 2019 – Sep 26, 2029ActiveRegistration details
- Analysis ID
- f98bfab4b1d0872b6ed05c3a29e6723b
Company information
- Manufacturer
- BIOPTIK TECHNOLOGY, INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- BIOPTIK TECHNOLOGY, INC.
Product details
- Intended Use
- Limited to the classification and grading management of medical equipment, triglycerides test system (A.1705) first grade identification range.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1705 Triglyceride Test System
- Import Information
- 國產;; QMS/QSD
Dates and status
- Registration Date
- Sep 26, 2019
- Expiry Date
- Sep 26, 2029
About this record
Access comprehensive regulatory information for Emex Advanced Triglyceride Monitoring System (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number f98bfab4b1d0872b6ed05c3a29e6723b and manufactured by BIOPTIK TECHNOLOGY, INC.. The authorized representative in Taiwan is BIOPTIK TECHNOLOGY, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices